The Aporia
Nyabiage, J. (2026, October 24). How competition between Chinese and Indian firms could reshape Africa’s drug markets. South China Morning Post. https://www.scmp.com/news/china/diplomacy/article/3371997/how-competition-between-chinese-and-indian-firms-could-reshape-africas-drug-markets
Nyabiage, Jevans. “How competition between Chinese and Indian firms could reshape Africa’s drug markets.” South China Morning Post, 24 Oct. 2026, https://www.scmp.com/news/china/diplomacy/article/3371997/how-competition-between-chinese-and-indian-firms-could-reshape-africas-drug-markets.
Nyabiage, Jevans. “How competition between Chinese and Indian firms could reshape Africa’s drug markets.” South China Morning Post, October 24, 2026. https://www.scmp.com/news/china/diplomacy/article/3371997/how-competition-between-chinese-and-indian-firms-could-reshape-africas-drug-markets.
Dated from the outlet's own feed. Check the original for its byline.
As of October 24, 2026, Chinese pharmaceutical firms are increasingly challenging India's dominance in Africa's antimalarial drug market. According to a new study by Indian market research company Sol Gravitas, Chinese exports of antimalarials reached US$89.3 million last year, nearly matching India’s US$89.6 million, compared to US$121 million for India and US$62.6 million for China in 2021. This shift highlights the growing competitiveness of China's pharmaceutical industry in Africa, particularly in the hardest-hit countries battling malaria. The study also analyzed Global Fund purchases for these countries between 2021 and 2025, indicating a significant narrowing gap in market share between Chinese and Indian firms over this period.